NGI Center at AD/PD 2023

The Alzheimer’s Disease/Parkinson’s disease (AD/PD) 2023 annual conference ( begins tomorrow and will continue through Saturday, April 1. The virtual conference provides 6 full days of scientific presentations and symposia including a mix of pre-recorded oral presentations and live discussions with presenters.
The Cruchaga lab is represented by 13 of our own researchers who are presenting their recent work on Alzheimer and Parkinson’s diseases. The center will also have 6 ePosters on display throughout the conference. The contributions to this year’s conference stretches across many “omic” approaches to identify risk factors, biomarkers, and drug targets that will help progress the field of neurodegenerative disease study.
We would like to recognize the hard work done by each of our presenters. The presenters and the title of their talks and posters are listed below:

Priyanka Gorijala
o Oral presentation On-Demand (Virtual) 3/29, 12:00am-1:30amCT (7am-8:30CET)
o Alzheimer’s Disease Risk PRS is Associated with Dementia and Memory Phenotypes in Down Syndrome

Da Hun Seo
o Oral Presentation (On-site) 3/29, 3:40am-3:55amCT (10:40-10:55CET)
o Sex and Age Specific CSF Proteomic Signatures and Link to Chronic Diseases

Laura Ibanez
o Oral presentation (On-site) 3/29, 10:20am-12:20pmCT (5:20pm-7:20pmCET)
o Circular RNAs Association with Idiopathic Parkinson’s Disease: Case Control study results in PPMI Dataset

Bridget Phillips
o Oral presentation On-Demand (Virtual) 3/31, 12:00am-1:30amCT (7am-8:30amCET)
o Protein Phewas of LRRK2 Variants Identified Novel Causal Proteins and Pathways for Parkinson’s Disease

Yun Ju Sung
o Oral presentation (On-site) 3/31, 1:40am-3:40amCT (8:40am-10:40amCET)
o GWAS for Soluble TREM2 Levels in CSF Identifies New Loci Involved in TREM2 Biology and Alzheimer’s Disease

Anh Do
o Oral presentation On-Demand (Virtual) 4/1, 12:00am-1:30amCT (7am-8:30amCET)
o Sex-Specific SCF Proteomic Profiling of Sporadic Alzheimer’s Disease

Joseph Bradley
o Oral presentation On-Demand (Virtual) 4/1, 12:00am-1:30amCT (7am-8:30amCET)
o Multi-Ethnic Meta-Analysis of Earlier Onset Alzheimer’s Disease Identifies Novel Risk Loci
o Paper + ePoster Presentation (Virtual): Genetic Architecture of Plasma Alzheimer Disease Biomarkers.

Carlos Cruchaga

o Oral presentation On-Demand (Virtual) 3/31, 1:40am-3:40amCT (8:40am-10:40amCET)
o GWAS for Soluble TREM2 levels in CSF identifies new loci involved in TREM2 Biology and Alzheimer’s Disease
o Oral presentation On-Demand (Virtual) 4/1, 12:00am-1:30amCT (7am-8:30amCET)
o Multi-Tissue Proteomics Identifies Molecular Signatures for Sporadic and Genetically Define Alzheimer Disease Cases

Dan Western
o Oral presentation (On-site) 4/1 4:10am-6:10amCT (11:10am-1:10pmCET)
o Cerebrospinal fluid pQTL and follow-up PWAS identifies multiple novel causative proteins for Alzheimer’s Disease

Aleksandra Beric
o Poster On-site and ePoster: Plasma Cell-free RNA: A Promising Biomarker for Parkinson’s Disease
o Poster Onsite and ePoster: Small RNAs, Short but Mighty: The Unknown Players in AD Pathobiology

Ciyang Wang
o Poster (On-site) and e-Poster Presentation (Virtual)
o Genetic Determinants of Human Metabolites in CSF and Brain-Link Metabolites to 15 Brain-Related Traits and Diseases

Muhammad Ali
o Paper (On-site) and e-Poster Presentation (Virtual)
o Using Amyloid PET as a Biomarker to detect progression of early Alzheimer’s Disease

Lihua Wang
o Paper (On-site) and e-Poster Presentation (Virtual)
o Plasma Proteomics of SARS-COV-2 Infection Point to Changes on Alzheimer and Coronary Disease Pathways

Visit to view the interactive scientific program and ePoster gallery. If you are registered for the AD/PD conference you can watch the talks and view the ePosters.

Leave a Reply

Your email address will not be published. Required fields are marked *